N/A
N=278
Surgical Approach for Pilonidal Disease
Pilonidal Disease
Bottom Line
View on ClinicalTrials.gov: NCT04334681 ↗Enrolled (actual)
278
Serious AEs
1.1%
Results posted
Feb 2021
Primary outcome: Primary: Mobilization Time,Days — 3.21; 12.3 days
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Un-roofing curettage method (Procedure); Modified Limberg Flap Group (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Konya Meram State Hospital
- Primary completion
- Sep 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mobilization Time,Days |
3.21; 12.3 | — |
| PRIMARY Number of Participants With Recurring Disease |
6; 2 | — |
| PRIMARY Operation Time |
11.44; 52.47 | — |
| PRIMARY Hospitalization Time |
0.24; 1.07 | — |
Summary
In our hospital, between January 2013 and January 2017, those operated with the Modified Limberg flap method after the Rhomboid excision due to pilonidal disease, and those operated with the un-roofing curettage method will be screened retrospectively. Patients will be divided into two groups as Un-roofing curettage group (UC group) and the Modified Limberg Flap group (LF group). Operation time, hospital stay time, return to work time, recovery time, Time to walk without pain, days, Time to sit on the toilet without pain, days, Postoperative VAS and recurrence will be compared between both groups
Eligibility Criteria
Inclusion Criteria
- Patients between the ages of 18 and 70
- Patients with sufficient registration information
- Telephone-accessible patients
Exclusion Criteria
- Patients under the age of 18
- Patients over 70 years old
- Common gluteal disease
- Diabetes mellitus
- Connective tissue disease
Data sourced from ClinicalTrials.gov (NCT04334681). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.